Search

Search Results

• Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

  Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

  13-09-2023

  https://doi.org/10.4081/dr.2023.9839

  2187

  PDF: 810

  HTML: 22
• 

  Possible relationship between poor skin disorders prognosis and serum zinc level: a narrative review

  Mohammed Al Abadie, Zinah Sharara, Miriam Al Abadie, Patrick A. Ball, Hana Morrissey

  06-07-2022

  https://doi.org/10.4081/dr.2022.9512

  1875

  PDF: 799

  HTML: 216
• 

  Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

  Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza

  21-11-2022

  https://doi.org/10.4081/dr.2022.9447

  1166

  PDF: 335

  HTML: 38
• 

  An epidemiological study of 97 cases of primary cicatricial alopecia in Iran

  Akram Beheshtiroy, Fatemeh Hajmanoochehri, Fahim Hossienghamar

  18-06-2015

  https://doi.org/10.4081/dr.2015.5960

  1753

  PDF: 860

  HTML: 243
• 

  Familial amyloidosis cutis dyschromica in three siblings: report from Indonesia

  Melyawati Hermawan, Rahadi Rihatmadja, Sondang Pandjaitan Sirait

  03-11-2014

  https://doi.org/10.4081/dr.2014.5375

  1473

  PDF: 621

  HTML: 1100

• Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

  Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota

  11-11-2024

  https://doi.org/10.4081/dr.2024.10140

  636

  PDF: 290

  SUPPLEMENTARY: 49